News | Mammography
The Medicare Shared Savings Program (MSSP) has produced small but significant improvements in mammography utilization in its first three years, according to a new study published online in the journal Radiology.
September 28, 2016 
News | Radiation Therapy
Although approximately 50 percent of cancer patients in developing countries need radiation therapy (RT), up to half of these patients do not have access to it, according to new research. The research was presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston.
September 28, 2016 
News | Cardio-oncology
In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for prostate cancer had a net harm if they had a prior history of a heart attack. The findings were presented at the American Society for Radiation Oncology (ASTRO) meeting, Sept. 25-28 in Boston.
September 28, 2016 Sponsored Content
Sponsored Content
Videos | Radiology Business
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
November 11, 2025 
Blog | Information Technology
If we are to look forward to the development of smartphone technology for radiology applications, we might do well to look at virtual and augmented realities. For decades, radiology has fiddled with these.
September 28, 2016 
News | Computed Tomography (CT)
Samsung announced recently that The University of Texas MD Anderson Cancer Center in Houston added BodyTom CT, the world’s first portable, full-body, 32-slice computed tomography (CT) scanner to its Proton Therapy Center. The center is now treating patients using images from the scanner as part of the process.
September 28, 2016 
News | Breast Density
September 28, 2016 – Addressing the educational needs of an underserved and growing population, DenseBreast-info.org now ...
September 28, 2016 Sponsored Content
Feature | Breast Imaging
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
October 24, 2025 News | Radiation Therapy
Survival rates for elderly patients receiving stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to new research. The research was presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston.
September 27, 2016 
News | Prostate Cancer
September 27, 2016 — For men with early stage, low-risk prostate cancer, hypofractionated radiation therapy (RT) offers ...
September 27, 2016 
News | Radiology Imaging
September 27, 2016 — Carestream Health announced that it will be displaying a wide range of products at the 2016 Annual ...
September 27, 2016 Sponsored Content
Sponsored Content
Videos | Radiology Business
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
October 09, 2025 
News | Radiation Therapy
For patients who have cancer that has metastasized to the brain, stereotactic radiosurgery (SRS) results in statistically comparable survival rates, reduced cognitive decline and better quality of life (QOL), compared to whole brain radiotherapy (WBRT). These findings were drawn from research presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston.
September 27, 2016 
News | Radiation Therapy
Elekta announced that it has expanded its partnership with Radiating Hope, a volunteer organization that provides radiation equipment to resource-constrained countries. The organization also educates medical physics and radiation oncology personnel in those countries to help better serve their patient populations.
September 27, 2016 
News | Prostate Cancer
In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival. Identifying these subtypes can assist in future research to determine how patients will respond to treatment, according to research presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO). Findings represent a step toward the implementation of personalized medicine in prostate cancer care.
September 26, 2016 Sponsored Content
Case Study | PACS
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
February 03, 2025 
News | Radiation Therapy
RaySearch and Mevion Medical Systems are extending their collaboration agreement to support the RayCare oncology information system (OIS), currently in development at RaySearch, and to take full advantage of the advanced treatment capabilities of the Mevion S250i with Hyperscan and Adaptive Aperture. The agreement was announced at the 58th annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston.
September 26, 2016 News | Lung Imaging
September 26, 2016 — A new analysis of Veteran’s Affairs Central Cancer Registry records demonstrates a clear positive ...
September 26, 2016 
News | Proton Therapy
September 26, 2016 — IBA (Ion Beam Applications S.A.) and Philips announced that they are stepping up their combined ...
September 26, 2016 
News | Prostate Cancer
September 26, 2016 — For men with intermediate-risk prostate cancer, side effects at two years following radiation ...
September 26, 2016 
News | Radiation Therapy
Stereotactic radiosurgery (SRS) for brain metastases decreases the likelihood of local recurrence but shows no positive difference in terms of overall survival (OS) or distant brain metastases (DBMs) rates compared to observation alone following surgical resection. These conclusions were drawn from research presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).
September 26, 2016 
News | Radiation Therapy
September 26, 2016 — At the American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 25-28 in Boston ...
September 26, 2016 
News | Lung Imaging
New research suggests hypofractionated radiation therapy (RT) offers similar results to standard RT in several key areas for stage II and III non-small cell lung cancer (NSCLC) patients who are unable to receive standard treatments of surgery or chemoradiation (CRT). Hypofractionated RT showed similar results in overall survival (OS) and progression-free survival (PFS) rates, limited severe side effects and shorter treatment times.
September 26, 2016 News | Proton Therapy
September 23, 2016 — IBA unveiled its new platform, 'Leading the PATh', which gathers the leading experts in the field ...
September 23, 2016 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now